Pregled bibliografske jedinice broj: 730773
Cathepsin D and Its Prognostic Value in Neuroepithelial Brain Tumors
Cathepsin D and Its Prognostic Value in Neuroepithelial Brain Tumors // Collegium antropologicum, 36 (2012), 1; 227-233 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 730773 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cathepsin D and Its Prognostic Value in Neuroepithelial Brain Tumors
Autori
Pigac, Biserka ; Dmitrović, Branko ; Marić, Svjetlana ; Mašić, Silvija
Izvornik
Collegium antropologicum (0350-6134) 36
(2012), 1;
227-233
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
cathepsin D ; prognostic value ; glioma ; medulloblastoma
Sažetak
Expression of Cathepsin D (Cath D) in some primary neuroepithelial brain tumors and its prognostic value were studied. The research included 65 samples of human primary neuroepithelial brain tumors. There were 50 glial tumors (10 diffuse astrocytomas (DA), 15 anaplastic astrocytomas (AA), 25 glioblastomas (GB), 15 embryonic tumors (15 medulloblastomas(MB) as well as 5 samples of normal brain tissue. Immunohistochemical method was applied to monitor diffuse positive reaction in the cytoplasm of brain tumor cells, endothelial cells and tumor stromal cells and showed diffuse positive reaction for Cath D in the cytoplasm of brain tumor cells, endothelial cells and stromal cells in all analyzed samples of DA, AA, GB and MB as well as in microglial cells, neurons and in endothelial cells in all analyzed samples of normal brain tissue. Qualitative analysis of Cath D expression in the cytoplasm of brain tumor cells and endothelial cells as well as the percentage of brain tumor cells, endothelial cells and stromal cells immunopositive for Cath D showed that there was difference between analyzed brain tumor groups, but according to statistical tests the difference was not statistically significant. Survival correlated with the percentage of stromal cells immunopositive for Cath D. Survival prognosis was influenced by the percentage of stromal cells immunopositive for Cath D and tumor grade. The obtained results singled out the percentage of stromal cells immunopositive for Cath D as an independent parameter. The results of this research on the prognostic value of Cath D in some primary brain tumors of neuroepithelial origin indicate that there is real possibility to use Cath D as an independent prognostic factor in human glioma progression and thus open up possibilities for further scientific research.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Osijek,
Opća bolnica Varaždin,
Medicinski fakultet, Osijek
Profili:
Branko Dmitrović
(autor)
Biserka Pigac
(autor)
Svjetlana Marić
(autor)
Silvija Mašić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE